Abstract
Celiac disease (CD) is a permanent intolerance to gluten that results in damage of the small intestinal mucosa, and it is one of the common causes of chronic malabsorption in Caucasian children. In CD children, short stature could be the only presenting clinical feature, even in absence of gastroinstestinal symptoms. Generally, withdrawal of gluten from the diet leads to a rapid catch-up growth of body weight within 6-12 months, whereas the height catches up more gradually. A degree of dysfunction of the endocrine axis could be observed in children with CD, but the pituitary function usually normalized after the institution of gluten-free diet. On the other hand, it has been previously reported some patients with isolated and multiple GH deficiency (GHD) showing no catch-up growth during a gluten-free diet, in spite of reversion to seronegativity for EMA. These patients could benefit from substitutive GH therapy as idiopathic GHD ones. This review deals with the problem of linear growth in CD children and points to the importance of the evaluation of GH secretion in those children who showed no catch-up growth after the introduction of gluten-free diet in order to start a GH replacement therapy whether GHD is documented.
Keywords: Celiac disease, short stature, growth hormone, growth hormone deficiency, anti-endomysial antibodies, glutenfree diet
Current Pediatric Reviews
Title: Growth Retardation in Children with Celiac Disease
Volume: 4 Issue: 3
Author(s): Cristina Meazza, Pagani Sara, Giovenale Diletta, Kamilia Laarej and Bozzola Mauro
Affiliation:
Keywords: Celiac disease, short stature, growth hormone, growth hormone deficiency, anti-endomysial antibodies, glutenfree diet
Abstract: Celiac disease (CD) is a permanent intolerance to gluten that results in damage of the small intestinal mucosa, and it is one of the common causes of chronic malabsorption in Caucasian children. In CD children, short stature could be the only presenting clinical feature, even in absence of gastroinstestinal symptoms. Generally, withdrawal of gluten from the diet leads to a rapid catch-up growth of body weight within 6-12 months, whereas the height catches up more gradually. A degree of dysfunction of the endocrine axis could be observed in children with CD, but the pituitary function usually normalized after the institution of gluten-free diet. On the other hand, it has been previously reported some patients with isolated and multiple GH deficiency (GHD) showing no catch-up growth during a gluten-free diet, in spite of reversion to seronegativity for EMA. These patients could benefit from substitutive GH therapy as idiopathic GHD ones. This review deals with the problem of linear growth in CD children and points to the importance of the evaluation of GH secretion in those children who showed no catch-up growth after the introduction of gluten-free diet in order to start a GH replacement therapy whether GHD is documented.
Export Options
About this article
Cite this article as:
Meazza Cristina, Sara Pagani, Diletta Giovenale, Laarej Kamilia and Mauro Bozzola, Growth Retardation in Children with Celiac Disease, Current Pediatric Reviews 2008; 4 (3) . https://dx.doi.org/10.2174/157339608785856009
DOI https://dx.doi.org/10.2174/157339608785856009 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews Foreword [The Largest Unmet Market: Chronic Diseases of Aging]
Mini-Reviews in Medicinal Chemistry The Role of H. pylori Infection in Diabetes
Current Diabetes Reviews Dexrazoxane for the Prevention of Cardiac Toxicity and Treatment of Extravasation Injury from the Anthracycline Antibiotics
Current Pharmaceutical Biotechnology Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies
Current Topics in Medicinal Chemistry Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Abnormal Cytokine Production by Circulating Monocytes and Dendritic Cells of Myeloid Origin in ART-Treated HIV-1+ Patients Relates to CD4+ T-Cell Recovery and HCV Co-Infection
Current HIV Research WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
Anti-Cancer Agents in Medicinal Chemistry Recent Progress in Anticonvulsant Drug Research: Strategies for Anticonvulsant Drug Development and Applications of Antiepileptic Drugs for Non-Epileptic Central Nervous System Disorders
Current Topics in Medicinal Chemistry Vitamin D and the Adaptive Immune System with Special Emphasis to Allergic Reactions and Allograft Rejection
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice
Current Pediatric Reviews Immune Aging and Autoimmune Diseases in Children
Current Immunology Reviews (Discontinued) Functional Genomics- and Network-driven Systems Biology Approaches for Pharmacogenomics and Toxicogenomics
Current Drug Metabolism Development of Mitotane Lipid Nanocarriers and Enantiomers: Two-in-One Solution to Efficiently Treat Adreno-Cortical Carcinoma
Current Medicinal Chemistry Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors
Central Nervous System Agents in Medicinal Chemistry Chronographic Theory of Development, Aging, and Origin of Cancer: Role of Chronomeres and Printomeres
Current Aging Science Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Current Drug Targets Emergence of Azole Therapy for Cancer Associated Fungal Infections and Their Potential Human Toxicity
The Natural Products Journal